Biotech Values

[apljack]

NGNM: New Coverage by B. Riley & Co.

I am not a subscriber to their research so have just the public notice of their coverage, which was initiated today. The PR reads as follows:

"NeoGenomics, Inc. is a high-complexity cancer genetics laboratory that addresses the anatomic pathology and oncology markets’ inquiries related to diagnosis, prognosis, and therapy selection for hematologic and solid tumor cancers. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. The company markets its services to pathologists, oncologist, urologists, hospitals, and other clinical laboratories. The company was founded in 2001 and is headquartered in Fort Myers, Florida."

Coverage initiated as a "buy" with a price target of $4.60. This may explain the volume and price move last week.

http://brileyco.com/research/coverage_list/neogenomics_inc/

aj